Biotec BetaGlucans was established as a subsidiary of Biotec Pharmacon with the aim to further develop and market a wound healing dressing for stalled wounds with beta-1,3/1,6-glucan as the ancillary compound.
Woulgan Bioactive Beta-Glucan Gel is an active wound healing product containing soluble beta-glucan (SBG). The product provides an optimal moist wound-healing environment, re-hydrates necrotic tissue and aids in autolytic debridement. The active ingredient in Woulgan is soluble beta-glucan (SBG), a proprietary substance shown to promote angiogenesis, cell proliferation and wound contraction.
Apart from the development and production of Woulgan, Biotec BetaGlucans is also doing research on the effect of beta-glucan on cancer, asthma and inflammatory bowel disease. The company has developed M-Gard®, an immunomodulator that enhances your body’s vital defence mechanisms against pathogens such as bacteria, virus, fungus etc. Studies have shown that M-Gard® exert immunomodulatory effects in vitro and in vivo in experimental animal and human models. M-Gard® represent an excellent immune enhancing compound for human use.